14-day Premium Trial Subscription Sign Up For FreeGet Free

Endologix Stock Forecast NASDAQ:ELGX

$0.0737 (0%)

Volume: 0

Closed: Jan 19, 2022

Hollow Logo Score: 0.000

Endologix Stock Forecast

$0.0737 (0%)

Volume: 0

Closed: Jan 19, 2022

Score Hollow Logo 0.000

Endologix Company Profile

2 Musick

Irvine CA 92618

949-595-7200

endologix.com

Endologix

Description

Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. The company offers minimally-invasive endovascular repair (EVAR) products, including EVAR stent graft and catheter delivery system under the Powerlink, IntuiTrak, AFX, and VELA Proximal Endograft brand names. It also provides endovascular sealing (EVAS) product that is based on the Nellix EVAS system to seal the aneurysm, and provides blood flow to the legs through two blood lumens. In addition, the company offers proximal aortic extensions and limb extensions, which attach to the main body of its EVAR device, allowing physicians to customize it to fit the patient’s anatomy; and accessories to facilitate the optimal delivery of its EVAR products, including compatible guidewires, snares, and catheter introducer sheaths. It sells its products through direct sales force, network of agents, and independent distributors or agents. The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is headquartered in Irvine, California.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE